

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 7.82313917 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 7.62941461 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.84891218 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.66997550 |
| 5 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 6.23179723 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.10679979 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.95267131 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.95267131 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.95267131 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.95267131 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.95267131 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.95267131 |
| 13 | positive thymic T cell selection (GO:0045059) | 5.78822252 |
| 14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.67243525 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 5.65763064 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 5.54042059 |
| 17 | B cell proliferation (GO:0042100) | 5.17606629 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 5.10424714 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.03841893 |
| 20 | regulation of germinal center formation (GO:0002634) | 5.02587554 |
| 21 | regulation of B cell differentiation (GO:0045577) | 5.02239141 |
| 22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.99740312 |
| 23 | I-kappaB phosphorylation (GO:0007252) | 4.98960669 |
| 24 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 4.83351550 |
| 25 | regulation of antigen processing and presentation (GO:0002577) | 4.82290953 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 4.55050777 |
| 27 | positive T cell selection (GO:0043368) | 4.51068070 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 4.50474270 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.48621290 |
| 30 | detection of bacterium (GO:0016045) | 4.44326863 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.43621950 |
| 32 | negative thymic T cell selection (GO:0045060) | 4.30959292 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.29705877 |
| 34 | response to host immune response (GO:0052572) | 4.29705877 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 4.28873496 |
| 36 | respiratory burst (GO:0045730) | 4.28651804 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 4.23730037 |
| 38 | detection of other organism (GO:0098543) | 4.19069081 |
| 39 | regulation of interferon-alpha production (GO:0032647) | 4.15786243 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 4.06690047 |
| 41 | negative regulation of B cell apoptotic process (GO:0002903) | 4.05689481 |
| 42 | negative T cell selection (GO:0043383) | 4.04069210 |
| 43 | positive regulation of interferon-beta production (GO:0032728) | 4.03388161 |
| 44 | B cell mediated immunity (GO:0019724) | 3.99889347 |
| 45 | response to host (GO:0075136) | 3.96954314 |
| 46 | response to host defenses (GO:0052200) | 3.96954314 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.96954314 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.95952826 |
| 49 | defense response to protozoan (GO:0042832) | 3.90755896 |
| 50 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.85158274 |
| 51 | B cell homeostasis (GO:0001782) | 3.83241792 |
| 52 | T cell selection (GO:0045058) | 3.82328609 |
| 53 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.76748469 |
| 54 | positive regulation of B cell proliferation (GO:0030890) | 3.76729289 |
| 55 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.76544808 |
| 56 | positive regulation of B cell activation (GO:0050871) | 3.74981238 |
| 57 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.73549077 |
| 58 | negative regulation of cell killing (GO:0031342) | 3.73549077 |
| 59 | microglial cell activation (GO:0001774) | 3.71576193 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.69540902 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.68119317 |
| 62 | positive regulation of Rap GTPase activity (GO:0032854) | 3.62736287 |
| 63 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.62256239 |
| 64 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.62256239 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.59848265 |
| 66 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.57130323 |
| 67 | regulation of B cell proliferation (GO:0030888) | 3.56529544 |
| 68 | thymic T cell selection (GO:0045061) | 3.52758456 |
| 69 | regulation of interferon-beta production (GO:0032648) | 3.50923132 |
| 70 | positive regulation of type 2 immune response (GO:0002830) | 3.48039233 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.47234060 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42670943 |
| 73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.40759368 |
| 74 | positive regulation of mast cell degranulation (GO:0043306) | 3.37034705 |
| 75 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.37034705 |
| 76 | reactive oxygen species biosynthetic process (GO:1903409) | 3.36588519 |
| 77 | response to protozoan (GO:0001562) | 3.35134928 |
| 78 | regulation of B cell apoptotic process (GO:0002902) | 3.33180405 |
| 79 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.32575067 |
| 80 | positive regulation of macrophage cytokine production (GO:0060907) | 3.26459615 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.23842159 |
| 82 | response to type I interferon (GO:0034340) | 3.21638017 |
| 83 | type I interferon signaling pathway (GO:0060337) | 3.19776677 |
| 84 | cellular response to type I interferon (GO:0071357) | 3.19776677 |
| 85 | megakaryocyte development (GO:0035855) | 3.17956233 |
| 86 | regulation of B cell activation (GO:0050864) | 3.17547025 |
| 87 | positive regulation of mast cell activation (GO:0033005) | 3.17001416 |
| 88 | macrophage activation (GO:0042116) | 3.12469955 |
| 89 | T cell migration (GO:0072678) | 3.10134109 |
| 90 | lymphocyte proliferation (GO:0046651) | 3.09525766 |
| 91 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.08577198 |
| 92 | mononuclear cell proliferation (GO:0032943) | 3.06004394 |
| 93 | regulation of Rap GTPase activity (GO:0032317) | 3.01213886 |
| 94 | detection of external biotic stimulus (GO:0098581) | 3.01181486 |
| 95 | negative regulation of B cell proliferation (GO:0030889) | 2.96811898 |
| 96 | positive regulation of interferon-gamma production (GO:0032729) | 2.94723023 |
| 97 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.93221849 |
| 98 | mature B cell differentiation (GO:0002335) | 2.90955444 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89904073 |
| 100 | T cell costimulation (GO:0031295) | 2.89278390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.34639744 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.29816933 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.23276296 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.76483066 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.66650105 |
| 6 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.35672379 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34206389 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.28380934 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.95646728 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.95444614 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82014628 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.69219959 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54888192 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52060354 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48904996 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45785760 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.35833772 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.33654746 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22074053 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.20606255 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.20244853 |
| 22 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.19853610 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18064342 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.17309512 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14756781 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.13381614 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08258771 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05640982 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02377456 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.94184659 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91336947 |
| 32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81596553 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80204618 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79537465 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.73659792 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.72152630 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69611973 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69479569 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68549523 |
| 40 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.67588015 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66838960 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65799721 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62863489 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.62847345 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62193358 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59528217 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.56049487 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54392566 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53040991 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52853857 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48345151 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43964879 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43126480 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41371149 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39068578 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38472135 |
| 57 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.36617354 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35589786 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33261675 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32129714 |
| 61 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.30419697 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28172294 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28028911 |
| 64 | P300_27268052_Chip-Seq_Bcells_Human | 1.27974980 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27307844 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25789148 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24933245 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22241207 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.19063162 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18117399 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17620981 |
| 72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15411041 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15252786 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13296028 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10590664 |
| 76 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07643634 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07214234 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04982832 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04286603 |
| 80 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.03309020 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02617671 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01899956 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98817769 |
| 84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97131299 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94257993 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94161303 |
| 87 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93346150 |
| 88 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.92321252 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90787477 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89972905 |
| 91 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89048472 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88957346 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88482700 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87107021 |
| 95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86615122 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86289962 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86037368 |
| 98 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85196243 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.83545727 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82567983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.31432748 |
| 2 | MP0001800_abnormal_humoral_immune | 4.48073563 |
| 3 | MP0005387_immune_system_phenotype | 4.37574224 |
| 4 | MP0001790_abnormal_immune_system | 4.37574224 |
| 5 | MP0005671_abnormal_response_to | 3.56345582 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.47716324 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.40294065 |
| 8 | MP0000685_abnormal_immune_system | 3.24913505 |
| 9 | MP0002723_abnormal_immune_serum | 3.20700403 |
| 10 | MP0002420_abnormal_adaptive_immunity | 3.14765072 |
| 11 | MP0001819_abnormal_immune_cell | 3.10198685 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.06448607 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.93842364 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.79017722 |
| 15 | MP0002398_abnormal_bone_marrow | 2.69864422 |
| 16 | MP0005025_abnormal_response_to | 2.61562451 |
| 17 | MP0003303_peritoneal_inflammation | 2.59047493 |
| 18 | MP0000689_abnormal_spleen_morphology | 2.53057286 |
| 19 | MP0000716_abnormal_immune_system | 2.46010303 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.39275970 |
| 21 | MP0002419_abnormal_innate_immunity | 2.31651348 |
| 22 | MP0005310_abnormal_salivary_gland | 2.27279803 |
| 23 | MP0003436_decreased_susceptibility_to | 2.22430253 |
| 24 | MP0009785_altered_susceptibility_to | 2.21914931 |
| 25 | MP0000465_gastrointestinal_hemorrhage | 2.17486677 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.13236542 |
| 27 | MP0003724_increased_susceptibility_to | 2.08214938 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 2.00431807 |
| 29 | MP0002429_abnormal_blood_cell | 1.95439652 |
| 30 | MP0002405_respiratory_system_inflammati | 1.95254935 |
| 31 | MP0002722_abnormal_immune_system | 1.94592229 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.86895400 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.85752559 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.67070944 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.62239295 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.56826817 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.52800133 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.47014756 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.44282903 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.42257843 |
| 41 | MP0002928_abnormal_bile_duct | 1.40707067 |
| 42 | MP0009278_abnormal_bone_marrow | 1.33888031 |
| 43 | MP0008260_abnormal_autophagy | 1.33067141 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.25925167 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.25925167 |
| 46 | MP0001348_abnormal_lacrimal_gland | 1.22775319 |
| 47 | MP0001873_stomach_inflammation | 1.20134792 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.19934019 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.19328607 |
| 50 | MP0008469_abnormal_protein_level | 1.14756122 |
| 51 | MP0004947_skin_inflammation | 1.13559204 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.12904298 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.10829439 |
| 54 | MP0009384_cardiac_valve_regurgitation | 1.05121527 |
| 55 | MP0003866_abnormal_defecation | 0.96359735 |
| 56 | MP0001764_abnormal_homeostasis | 0.95370438 |
| 57 | MP0005166_decreased_susceptibility_to | 0.92393593 |
| 58 | MP0001853_heart_inflammation | 0.89804767 |
| 59 | MP0006082_CNS_inflammation | 0.89241345 |
| 60 | MP0004381_abnormal_hair_follicle | 0.87424093 |
| 61 | MP0003252_abnormal_bile_duct | 0.85321122 |
| 62 | MP0002006_tumorigenesis | 0.84915184 |
| 63 | MP0002019_abnormal_tumor_incidence | 0.82272402 |
| 64 | MP0002095_abnormal_skin_pigmentation | 0.82014912 |
| 65 | MP0003045_fibrosis | 0.80184120 |
| 66 | MP0002933_joint_inflammation | 0.79719653 |
| 67 | MP0001533_abnormal_skeleton_physiology | 0.78976760 |
| 68 | MP0002638_abnormal_pupillary_reflex | 0.77069573 |
| 69 | MP0003787_abnormal_imprinting | 0.73736907 |
| 70 | MP0002009_preneoplasia | 0.71992200 |
| 71 | MP0004883_abnormal_blood_vessel | 0.71823695 |
| 72 | MP0001663_abnormal_digestive_system | 0.69298062 |
| 73 | MP0000371_diluted_coat_color | 0.67321729 |
| 74 | MP0008877_abnormal_DNA_methylation | 0.63561439 |
| 75 | MP0000249_abnormal_blood_vessel | 0.62568513 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.60930441 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.59128607 |
| 78 | MP0004147_increased_porphyrin_level | 0.59013501 |
| 79 | MP0003690_abnormal_glial_cell | 0.58394079 |
| 80 | MP0008004_abnormal_stomach_pH | 0.57700893 |
| 81 | MP0009764_decreased_sensitivity_to | 0.57687591 |
| 82 | MP0005381_digestive/alimentary_phenotyp | 0.54198482 |
| 83 | MP0005451_abnormal_body_composition | 0.53146102 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52624392 |
| 85 | MP0000490_abnormal_crypts_of | 0.52533669 |
| 86 | MP0002132_abnormal_respiratory_system | 0.51966170 |
| 87 | MP0003077_abnormal_cell_cycle | 0.51414058 |
| 88 | MP0009763_increased_sensitivity_to | 0.49799886 |
| 89 | MP0000313_abnormal_cell_death | 0.48113844 |
| 90 | MP0001958_emphysema | 0.47177926 |
| 91 | MP0000858_altered_metastatic_potential | 0.46972049 |
| 92 | MP0005621_abnormal_cell_physiology | 0.46589560 |
| 93 | MP0008874_decreased_physiological_sensi | 0.46242860 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.45993010 |
| 95 | MP0003828_pulmonary_edema | 0.45515491 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.43223352 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.42243572 |
| 98 | MP0001851_eye_inflammation | 0.40535765 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.38929069 |
| 100 | MP0003075_altered_response_to | 0.38814296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cellulitis (HP:0100658) | 7.06387165 |
| 2 | Recurrent bronchitis (HP:0002837) | 6.56928466 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.92661578 |
| 4 | Meningitis (HP:0001287) | 5.85686848 |
| 5 | Gastrointestinal stroma tumor (HP:0100723) | 5.59154252 |
| 6 | Verrucae (HP:0200043) | 5.52381384 |
| 7 | Papilloma (HP:0012740) | 5.52381384 |
| 8 | Recurrent pneumonia (HP:0006532) | 5.47380478 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 5.11036744 |
| 10 | Osteomyelitis (HP:0002754) | 4.99675828 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.72070423 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.47098438 |
| 13 | Recurrent sinusitis (HP:0011108) | 4.36586481 |
| 14 | Colitis (HP:0002583) | 4.36585932 |
| 15 | Recurrent lower respiratory tract infections (HP:0002783) | 4.29622463 |
| 16 | Recurrent viral infections (HP:0004429) | 4.16182120 |
| 17 | Chronic sinusitis (HP:0011109) | 4.12818852 |
| 18 | Recurrent abscess formation (HP:0002722) | 4.12339915 |
| 19 | Recurrent fungal infections (HP:0002841) | 4.04674283 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.99368941 |
| 21 | Sepsis (HP:0100806) | 3.89835195 |
| 22 | Bronchitis (HP:0012387) | 3.87902427 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.86072703 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.85728372 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.84976587 |
| 26 | Vasculitis (HP:0002633) | 3.81444925 |
| 27 | Obstructive lung disease (HP:0006536) | 3.71675967 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.71675967 |
| 29 | Lymphopenia (HP:0001888) | 3.71556721 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.59919114 |
| 31 | Abnormality of B cell number (HP:0010975) | 3.47657016 |
| 32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.47122319 |
| 33 | B lymphocytopenia (HP:0010976) | 3.41108085 |
| 34 | Visual hallucinations (HP:0002367) | 3.28518781 |
| 35 | Restrictive lung disease (HP:0002091) | 3.22526745 |
| 36 | Recurrent otitis media (HP:0000403) | 3.16580575 |
| 37 | Skin rash (HP:0000988) | 3.10521668 |
| 38 | Encephalitis (HP:0002383) | 3.05289704 |
| 39 | Recurrent skin infections (HP:0001581) | 3.02321934 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91986803 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91986803 |
| 42 | Emphysema (HP:0002097) | 2.88559701 |
| 43 | Urticaria (HP:0001025) | 2.84452260 |
| 44 | Increased IgE level (HP:0003212) | 2.82544099 |
| 45 | IgG deficiency (HP:0004315) | 2.77142551 |
| 46 | Gingivitis (HP:0000230) | 2.59658053 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57494309 |
| 48 | Skin ulcer (HP:0200042) | 2.55995507 |
| 49 | Granulocytopenia (HP:0001913) | 2.54623776 |
| 50 | Microvesicular hepatic steatosis (HP:0001414) | 2.53264026 |
| 51 | Neurodegeneration (HP:0002180) | 2.44773895 |
| 52 | Myositis (HP:0100614) | 2.38529796 |
| 53 | Viral hepatitis (HP:0006562) | 2.36715101 |
| 54 | Peripheral hypomyelination (HP:0007182) | 2.36509581 |
| 55 | Lymphoma (HP:0002665) | 2.35055588 |
| 56 | IgA deficiency (HP:0002720) | 2.34465944 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.34289151 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.33018133 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.32840359 |
| 60 | Stomatitis (HP:0010280) | 2.29231521 |
| 61 | Abnormality of T cells (HP:0002843) | 2.28321478 |
| 62 | Optic neuritis (HP:0100653) | 2.26663007 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.26663007 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.25236245 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.20745448 |
| 66 | IgM deficiency (HP:0002850) | 2.18269724 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.18252360 |
| 68 | Dehydration (HP:0001944) | 2.16572398 |
| 69 | Neutropenia (HP:0001875) | 2.14895723 |
| 70 | Abnormality of the peritoneum (HP:0002585) | 2.09823652 |
| 71 | Leukopenia (HP:0001882) | 2.05606549 |
| 72 | Increased IgM level (HP:0003496) | 2.03869268 |
| 73 | Cervical subluxation (HP:0003308) | 2.02724106 |
| 74 | Orchitis (HP:0100796) | 2.00153838 |
| 75 | Chest pain (HP:0100749) | 2.00106182 |
| 76 | Agammaglobulinemia (HP:0004432) | 10.7201062 |
| 77 | Chronic otitis media (HP:0000389) | 1.95634677 |
| 78 | Fatigue (HP:0012378) | 1.95307680 |
| 79 | Pulmonary fibrosis (HP:0002206) | 1.92161124 |
| 80 | J-shaped sella turcica (HP:0002680) | 1.91278868 |
| 81 | Gingival bleeding (HP:0000225) | 1.90402352 |
| 82 | Epistaxis (HP:0000421) | 1.89940892 |
| 83 | Global brain atrophy (HP:0002283) | 1.89132730 |
| 84 | Eosinophilia (HP:0001880) | 1.86195319 |
| 85 | Broad face (HP:0000283) | 1.85904744 |
| 86 | Pustule (HP:0200039) | 1.84279994 |
| 87 | Leukocytosis (HP:0001974) | 1.81941782 |
| 88 | Acanthocytosis (HP:0001927) | 1.80296148 |
| 89 | Abnormality of the pleura (HP:0002103) | 1.79887273 |
| 90 | Hypertensive crisis (HP:0100735) | 1.79703630 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 1.76981074 |
| 92 | Abnormality of eosinophils (HP:0001879) | 1.76838208 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74124834 |
| 94 | Mucopolysacchariduria (HP:0008155) | 1.74124834 |
| 95 | Obstructive sleep apnea (HP:0002870) | 1.73953720 |
| 96 | Abnormality of T cell number (HP:0011839) | 1.73415880 |
| 97 | Hemoptysis (HP:0002105) | 1.72408657 |
| 98 | Hypoplasia of the thymus (HP:0000778) | 1.71064883 |
| 99 | Xerostomia (HP:0000217) | 1.69404101 |
| 100 | T lymphocytopenia (HP:0005403) | 1.69331052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.63935697 |
| 2 | MAP4K1 | 4.17987804 |
| 3 | IRAK4 | 3.30713439 |
| 4 | SYK | 3.08511911 |
| 5 | IKBKE | 3.03488406 |
| 6 | GRK6 | 2.96388975 |
| 7 | ERN1 | 2.82642484 |
| 8 | KIT | 2.81484160 |
| 9 | RIPK4 | 2.75517250 |
| 10 | TYK2 | 2.55074393 |
| 11 | BMPR2 | 2.36143066 |
| 12 | JAK3 | 2.19098382 |
| 13 | MAP3K13 | 2.14301668 |
| 14 | BTK | 2.13964457 |
| 15 | LYN | 2.09233659 |
| 16 | MAP2K3 | 1.81303788 |
| 17 | KDR | 1.79430115 |
| 18 | MAP3K11 | 1.74431438 |
| 19 | FES | 1.72257403 |
| 20 | ZAP70 | 1.69005713 |
| 21 | LCK | 1.60878494 |
| 22 | CDK12 | 1.54235977 |
| 23 | CSF1R | 1.50654225 |
| 24 | TBK1 | 1.43945842 |
| 25 | STK10 | 1.41782927 |
| 26 | JAK1 | 1.39663561 |
| 27 | ITK | 1.37489266 |
| 28 | TAOK3 | 1.36709947 |
| 29 | IKBKB | 1.36348538 |
| 30 | MAPK13 | 1.29800646 |
| 31 | MST4 | 1.23310819 |
| 32 | MAPK12 | 1.23073371 |
| 33 | MAP3K14 | 1.22176682 |
| 34 | TAOK1 | 1.21160719 |
| 35 | MAPK11 | 1.18340445 |
| 36 | PKN1 | 1.16679952 |
| 37 | MATK | 1.13771034 |
| 38 | TEC | 1.13750724 |
| 39 | MARK3 | 1.12316024 |
| 40 | CSK | 1.09066835 |
| 41 | HCK | 1.06621966 |
| 42 | ARAF | 1.03018160 |
| 43 | PIM1 | 1.02672270 |
| 44 | SCYL2 | 1.01839701 |
| 45 | FYN | 1.01838277 |
| 46 | CDC42BPA | 1.01413063 |
| 47 | PRPF4B | 0.98213047 |
| 48 | TXK | 0.95923015 |
| 49 | TNK2 | 0.94669849 |
| 50 | JAK2 | 0.93532697 |
| 51 | MAP3K10 | 0.91712939 |
| 52 | TESK2 | 0.86788610 |
| 53 | MAP3K5 | 0.86578932 |
| 54 | MAP3K3 | 0.85396697 |
| 55 | PRKCQ | 0.84189528 |
| 56 | MAP2K1 | 0.80841577 |
| 57 | MAP3K1 | 0.80082360 |
| 58 | MAP3K8 | 0.74500344 |
| 59 | TAOK2 | 0.73394333 |
| 60 | PRKD1 | 0.69695659 |
| 61 | NME2 | 0.68139933 |
| 62 | TLK1 | 0.67870028 |
| 63 | IRAK2 | 0.65213846 |
| 64 | LRRK2 | 0.64491020 |
| 65 | CDK4 | 0.64062158 |
| 66 | MAPKAPK2 | 0.64033412 |
| 67 | PRKD2 | 0.58312953 |
| 68 | SIK2 | 0.57164355 |
| 69 | RAF1 | 0.56451134 |
| 70 | STK4 | 0.55792352 |
| 71 | CHUK | 0.53541850 |
| 72 | GRK7 | 0.49866196 |
| 73 | FGFR4 | 0.47711717 |
| 74 | PDK1 | 0.47003330 |
| 75 | ADRBK1 | 0.46648868 |
| 76 | FGR | 0.45387939 |
| 77 | PIM2 | 0.44397126 |
| 78 | TGFBR2 | 0.42037776 |
| 79 | MARK2 | 0.39271242 |
| 80 | NUAK1 | 0.36862912 |
| 81 | DYRK1B | 0.36161372 |
| 82 | RPS6KA5 | 0.35417587 |
| 83 | MAPK3 | 0.33074258 |
| 84 | MOS | 0.32223279 |
| 85 | CCNB1 | 0.31171143 |
| 86 | SIK3 | 0.29851077 |
| 87 | MAPK4 | 0.29846439 |
| 88 | PRKCD | 0.28719700 |
| 89 | EGFR | 0.28684996 |
| 90 | GRK5 | 0.28527668 |
| 91 | PRKD3 | 0.26111843 |
| 92 | CLK1 | 0.25343183 |
| 93 | SGK2 | 0.23785798 |
| 94 | CSNK1D | 0.22403593 |
| 95 | INSR | 0.19482570 |
| 96 | PRKCZ | 0.18008058 |
| 97 | ROCK2 | 0.17752000 |
| 98 | FGFR3 | 0.17403529 |
| 99 | ABL1 | 0.16374812 |
| 100 | MAPK7 | 0.16342377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.46551428 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.25255412 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.12264457 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 4.06690574 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.78531507 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.77817344 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.61996784 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.22078211 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 3.00419248 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.57199495 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.48672673 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.42584698 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.22484073 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12742006 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.11716863 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94174910 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.82165494 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.73286212 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71954624 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.51650154 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50861323 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39652314 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.39385237 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37175938 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32976397 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31458894 |
| 27 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.14520025 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.14436150 |
| 29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.13583533 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07893060 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05983240 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01769541 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00237005 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00162390 |
| 35 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97513475 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 0.96754667 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93700222 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89158595 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88446875 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84977022 |
| 41 | Malaria_Homo sapiens_hsa05144 | 0.84460391 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 0.82745730 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78565909 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75632183 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.74472941 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73560924 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72403974 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 0.69090545 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68406691 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.68332527 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65988478 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64430403 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64272607 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.64238204 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62382246 |
| 56 | Homologous recombination_Homo sapiens_hsa03440 | 0.58572009 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.53387444 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52559708 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.50611950 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43772989 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43534206 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42825820 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39120854 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37838673 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35332937 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.34981343 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32443336 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.32420265 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.30831778 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28687396 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26362495 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25549954 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24289523 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23701925 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.22743332 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20072360 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20071033 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18282927 |
| 79 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.17831248 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17766639 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17453659 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16031620 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15295945 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14767615 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12322804 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.11286486 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.09199806 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.09161838 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.09053671 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.08439332 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.07934473 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.06471431 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05730183 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.05625231 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.04788115 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03705064 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03196646 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.01864386 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.00761728 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | -0.0026179 |

